Amphastar Pharmaceuticals Inc (AMPH)
44.55
+0.46
(+1.04%)
USD |
NASDAQ |
Nov 21, 16:00
44.54
-0.01
(-0.02%)
After-Hours: 20:00
Amphastar Pharmaceuticals Max Drawdown (5Y): 49.92% for Oct. 31, 2024
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| October 31, 2024 | 49.92% |
| September 30, 2024 | 49.92% |
| August 31, 2024 | 49.92% |
| July 31, 2024 | 49.92% |
| June 30, 2024 | 49.92% |
| May 31, 2024 | 49.92% |
| April 30, 2024 | 49.92% |
| March 31, 2024 | 49.92% |
| February 29, 2024 | 49.92% |
| January 31, 2024 | 49.92% |
| December 31, 2023 | 49.92% |
| November 30, 2023 | 49.92% |
| October 31, 2023 | 49.92% |
| September 30, 2023 | 49.92% |
| August 31, 2023 | 49.92% |
| July 31, 2023 | 49.92% |
| June 30, 2023 | 49.92% |
| May 31, 2023 | 49.92% |
| April 30, 2023 | 49.92% |
| March 31, 2023 | 49.92% |
| February 28, 2023 | 49.92% |
| January 31, 2023 | 49.92% |
| December 31, 2022 | 49.92% |
| November 30, 2022 | 49.92% |
| October 31, 2022 | 49.92% |
| Date | Value |
|---|---|
| September 30, 2022 | 49.92% |
| August 31, 2022 | 49.92% |
| July 31, 2022 | 49.92% |
| June 30, 2022 | 49.92% |
| May 31, 2022 | 49.92% |
| April 30, 2022 | 49.92% |
| March 31, 2022 | 49.92% |
| February 28, 2022 | 49.92% |
| January 31, 2022 | 49.92% |
| December 31, 2021 | 49.92% |
| November 30, 2021 | 49.92% |
| October 31, 2021 | 49.92% |
| September 30, 2021 | 49.92% |
| August 31, 2021 | 49.92% |
| July 31, 2021 | 49.92% |
| June 30, 2021 | 49.92% |
| May 31, 2021 | 49.92% |
| April 30, 2021 | 49.92% |
| March 31, 2021 | 49.92% |
| February 28, 2021 | 49.92% |
| January 31, 2021 | 49.92% |
| December 31, 2020 | 49.92% |
| November 30, 2020 | 49.92% |
| October 31, 2020 | 49.92% |
| September 30, 2020 | 49.92% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
43.39%
Minimum
Nov 2019
49.92%
Maximum
Mar 2020
49.49%
Average
49.92%
Median
Mar 2020
Max Drawdown (5Y) Benchmarks
| Eli Lilly and Co | 22.48% |
| BridgeBio Pharma Inc | -- |
| NovaBay Pharmaceuticals Inc | 99.98% |
| Palatin Technologies Inc | 97.38% |
| iBio Inc | 99.97% |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | 8.217 |
| Beta (5Y) | 0.8233 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 39.68% |
| Historical Sharpe Ratio (5Y) | 0.4749 |
| Historical Sortino (5Y) | 0.8639 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 15.82% |